Ignite Creation Date:
2025-12-24 @ 9:37 PM
Ignite Modification Date:
2026-02-22 @ 1:34 AM
Study NCT ID:
NCT02084732
Status:
COMPLETED
Last Update Posted:
2019-11-13
First Post:
2014-03-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study
Sponsor:
Instituto Nacional de Cancerologia, Columbia
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
410-30610-258
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None